Increased attention allocation to stimuli reflecting end-states of compulsive behaviors among obsessive compulsive individuals.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 07 2023
Historique:
received: 11 04 2023
accepted: 25 07 2023
medline: 31 7 2023
pubmed: 28 7 2023
entrez: 27 7 2023
Statut: epublish

Résumé

Attentional research in OCD has focused solely on threat stimuli, assumed to provoke related obsessions and ensuing compulsions. OCD-related stimuli depicting the completion of compulsive acts ("end-states") have yet to be examined. Past research also neglected to explore the reliability of tasks used. Here, attention allocation to both stimuli types was examined. Participants with high (HOC) and low (LOC) levels of obsessive-compulsive symptoms freely viewed three blocks of 30 two-by-two picture matrices, each including two OCD-related (cleaning\checking\ordering) and two neutral pictures, presented for eight seconds, while their gaze was recorded. Participants completed two task versions - one with traditional threat stimuli and one with novel stimuli signaling compulsions end-states. Only the end-state version yielded significant results, showing that HOC participants, compared to LOC participants, spent significantly more time fixating on OCD-related stimuli. Results remained significant after controlling for anxiety, stress, and depression. Task reliability was high. OCD-related stimuli signaling end-states of compulsive behavior should be incorporated in attentional research in OCD.

Identifiants

pubmed: 37500711
doi: 10.1038/s41598-023-39459-x
pii: 10.1038/s41598-023-39459-x
pmc: PMC10374647
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12190

Informations de copyright

© 2023. The Author(s).

Références

Cyberpsychol Behav. 2007 Apr;10(2):299-304
pubmed: 17474851
Behav Res Ther. 1995 Mar;33(3):335-43
pubmed: 7726811
Behav Res Methods. 2016 Jun;48(2):600-12
pubmed: 26205422
Psychol Med. 2019 Apr;49(5):705-726
pubmed: 30178728
Cogn Behav Ther. 2006;35(3):138-47
pubmed: 16952897
Psychopharmacology (Berl). 2005 Jul;180(3):473-90
pubmed: 15731896
J Anxiety Disord. 2011 Jun;25(5):668-73
pubmed: 21477983
Depress Anxiety. 2019 Feb;36(2):121-129
pubmed: 30484928
Behav Res Ther. 2005 Mar;43(3):293-308
pubmed: 15680927
Psychol Med. 2021 Feb 26;:1-10
pubmed: 33634768
Behav Res Ther. 2008 Dec;46(12):1300-4
pubmed: 18951122
Addict Behav. 2020 Jan;100:106117
pubmed: 31522132
Clin Psychol Psychother. 2008 Jul-Aug;15(4):227-38
pubmed: 19115443
Philos Ethics Humanit Med. 2011 Feb 01;6:3
pubmed: 21284843
Clin Psychol Rev. 2019 Apr;69:4-13
pubmed: 29853421
Behav Res Ther. 2003 Nov;41(11):1311-23
pubmed: 14527530
Clin Psychol Rev. 2014 Apr;34(3):206-17
pubmed: 24561743
J Abnorm Psychol. 2014 Nov;123(4):695-704
pubmed: 25133987
Behav Res Ther. 2006 Oct;44(10):1471-9
pubmed: 16343418
J Affect Disord. 2020 Jul 1;272:28-37
pubmed: 32379617
Behav Res Ther. 2001 Aug;39(8):913-27
pubmed: 11480832
Behav Ther. 2021 Jul;52(4):995-1007
pubmed: 34134837
Clin Psychol Rev. 2014 Feb;34(1):1-13
pubmed: 24286750
Psychol Assess. 2002 Dec;14(4):485-96
pubmed: 12501574
J Behav Ther Exp Psychiatry. 2012 Jun;43(2):855-61
pubmed: 22217423
Emotion. 2010 Dec;10(6):822-30
pubmed: 21058839
Behav Ther. 2022 Jan;53(1):1-10
pubmed: 35027151
CNS Spectr. 2017 Jun;22(3):295-304
pubmed: 28065178
J Affect Disord. 2021 Mar 15;283:101-107
pubmed: 33535107
Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):
pubmed: 34074751
J Affect Disord. 2023 Mar 1;324:539-550
pubmed: 36610593
Psychiatry Res. 2009 Aug 15;168(3):238-41
pubmed: 19515429
Psychiatry Res. 2012 Jun 30;198(1):81-8
pubmed: 22414659
Behav Res Ther. 2002 Jun;40(6):625-39
pubmed: 12051482
Psychol Rev. 2004 Jan;111(1):33-51
pubmed: 14756584
J Affect Disord. 2016 Mar 15;193:282-8
pubmed: 26774515
Psychol Med. 2022 Jun 02;:1-9
pubmed: 35652602
Behav Res Ther. 1999 Nov;37(11):1055-72
pubmed: 10500320
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1977-82
pubmed: 21801779
Curr Opin Neurobiol. 2013 Aug;23(4):559-63
pubmed: 23628232
Am J Psychiatry. 2009 Mar;166(3):329-36
pubmed: 19188283
J Abnorm Psychol. 2012 Feb;121(1):232-7
pubmed: 21707123
Behav Res Methods. 2018 Oct;50(5):1778-1792
pubmed: 28812285
J Behav Ther Exp Psychiatry. 2016 Mar;50:303-8
pubmed: 26605829
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Behav Res Ther. 2004 Jan;42(1):115-23
pubmed: 14992204
J Abnorm Psychol. 1998 Aug;107(3):520-6
pubmed: 9715586
Br J Psychiatry Suppl. 1998;(35):53-63
pubmed: 9829027
Eur Arch Psychiatry Clin Neurosci. 2001 Jun;251(3):130-5
pubmed: 11697574
Behav Res Ther. 2003 Mar;41(3):369-78
pubmed: 12600406
J Anxiety Disord. 2010 Apr;24(3):293-9
pubmed: 20138463
PLoS One. 2012;7(9):e45938
pubmed: 23029329
Behav Res Ther. 2021 Dec;147:103987
pubmed: 34688103
J Affect Disord. 2021 Jul 1;290:169-177
pubmed: 34000570
Behav Res Ther. 2010 May;48(5):402-8
pubmed: 20138252
Biol Psychiatry. 2011 May 1;69(9):867-74
pubmed: 21272861
J Anxiety Disord. 2000 Sep-Oct;14(5):471-82
pubmed: 11095541
Mol Psychiatry. 2010 Jan;15(1):53-63
pubmed: 18725912
J Abnorm Psychol. 2010 Feb;119(1):136-42
pubmed: 20141250
Behav Res Ther. 2009 Jun;47(6):535-9
pubmed: 19342006
N Engl J Med. 2014 Aug 14;371(7):646-53
pubmed: 25119610
Br J Clin Psychol. 2005 Jun;44(Pt 2):227-39
pubmed: 16004657

Auteurs

Dana Basel (D)

School of Psychological Sciences, Tel Aviv University, 69978, Tel Aviv, Israel.

Moriah Magen (M)

School of Psychological Sciences, Tel Aviv University, 69978, Tel Aviv, Israel.

Amit Lazarov (A)

School of Psychological Sciences, Tel Aviv University, 69978, Tel Aviv, Israel. amitlaza@tauex.tau.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH